For the quarter ending 2026-04-04, USNA had $4,417K increase in cash & cash equivalents over the period. $7,114K in free cash flow.
| Cash Flow | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Net earnings | 6,959 | -1,595 | -6,662 | 19,734 |
| Depreciation and amortization | 8,277 | 8,561 | 7,919 | 16,082 |
| Right-of-use asset reduction | 1,512 | 1,725 | 1,648 | 3,767 |
| Loss on sale of property and equipment | -13 | 2,217 | -95 | -29 |
| Equity-based compensation expense | 3,454 | 3,750 | 3,576 | 6,502 |
| Deferred income taxes | 2,108 | -2,671 | 2,023 | -6,485 |
| Inventory write-down | 1,299 | 264 | 370 | 2,045 |
| Impairment | - | 6,967 | - | - |
| Trade accounts receivable | 5,367 | - | - | - |
| Inventories | -6,597 | 13,542 | 8,155 | 12,988 |
| Prepaid expenses and other assets | 1,689 | -820 | -261 | 460 |
| Accounts payable | -1,459 | 1,073 | -1,682 | 5,813 |
| Other liabilities | -11,945 | -6,525 | -1,354 | -6,339 |
| Proceeds from acquisition working capital adjustment | - | - | 0 | 865 |
| Net cash provided by (used in) operating activities | 9,759 | -3,390 | -1,961 | 27,700 |
| Proceeds from the settlement of net investment hedges | - | 0 | 0 | 0 |
| Payments for net investment hedge | 0 | 0 | 0 | 1,072 |
| Proceeds from acquisition working capital adjustment | - | 865 | - | - |
| Payments to acquire businesses, net of cash acquired | - | 0 | - | - |
| Proceeds from sale of property and equipment | 48 | 3,905 | 0 | 0 |
| Purchases of property and equipment | 2,645 | 2,795 | 3,198 | 7,830 |
| Net cash provided by (used in) investing activities | -2,597 | 1,110 | -3,198 | -8,037 |
| Repurchase of common stock | 0 | 0 | 0 | 27,507 |
| Borrowings on line of credit | 4,000 | 16,000 | 0 | 1,600 |
| Payments on line of credit | 4,000 | 2,000 | 0 | 24,600 |
| Payments related to tax withholding for net-share settled equity awards | 2,265 | 56 | 100 | 2,191 |
| Distributions to redeemable noncontrolling interest | 1,376 | 491 | 879 | 379 |
| Payments for contingent consideration | - | 0 | - | - |
| Net cash provided by (used in) financing activities | -3,641 | 13,453 | -979 | -53,077 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 896 | 1,914 | 165 | 3,032 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 4,417 | 13,087 | -5,973 | -30,382 |
| Cash, cash equivalents, and restricted cash at beginning of period | 161,240 | 148,153 | 184,508 | - |
| Cash, cash equivalents, and restricted cash at end of period | 165,657 | 161,240 | 148,153 | - |
USANA HEALTH SCIENCES INC (USNA)
USANA HEALTH SCIENCES INC (USNA)